Author: Leona Whitmore - Page 2
Future of Global Generic Markets: Key Predictions and Trends for 2025-2030
Explore the future of global generic drug markets with key predictions for 2025-2030. Learn about growth drivers, challenges, regional trends, and how biosimilars are reshaping affordable healthcare.
Medications Safe During Pregnancy: A Complete Patient List
A clear, evidence-based list of medications safe during pregnancy, including dosages, alternatives, and what to avoid. Covers pain relief, allergies, nausea, heartburn, and prescription drugs with expert guidance and real-world tips.
Night vs Morning Statin Dosing: What Really Matters for Side Effects and Effectiveness
The best time to take statins isn't night or morning - it's whenever you'll remember. Newer statins work equally well anytime; adherence matters more than clock time.
How to Talk to Your Doctor About Staying on a Brand Medication
Learn how to talk to your doctor about staying on a brand medication when generics aren't working for you. Get practical tips on documenting side effects, using SBAR, and appealing insurance denials.
How to Build a Personal Medication Safety Plan with Your Care Team
Learn how to create a personalized medication safety plan with your care team to prevent dangerous drug interactions, reduce side effects, and avoid accidental overdoses. Simple steps can save your life.
AI and Pharmacogenomics: How Personalized Generic Medication Recommendations Are Changing Online Pharmacies
AI is transforming how online pharmacies recommend generic drugs by using your genes to predict what’s safe and effective. Learn how pharmacogenomics works, where to get started, and why this could prevent dangerous side effects.
Manufacturing Changes: Notification and Approval Requirements in Pharmaceutical Production
Understand the regulatory requirements for manufacturing changes in pharmaceutical production, including FDA, EMA, and Health Canada rules for notification, approval, and compliance. Learn how to classify changes correctly and avoid costly violations.
FDA Listing for Biosimilars: How They Are Evaluated and Approved
The FDA doesn't rate biosimilars like generics-they undergo a rigorous scientific review to prove they're highly similar to the original biologic. Learn how approval works, what 'interchangeable' means, and why biosimilars are changing access to expensive treatments.
How to Report Medication Side Effects to Your Healthcare Provider Effectively
Learn how to clearly report medication side effects to your healthcare provider so your concerns are taken seriously and contribute to safer drug use for everyone. Includes practical steps, tools, and what happens after you speak up.
Authorized Generics vs Brand Drugs: What You Need to Know About These Identical Medications
Authorized generics are identical to brand-name drugs in every way-same ingredients, same manufacturer, same effectiveness. Learn how they differ from regular generics and when to ask for them at the pharmacy.
Paragraph IV Certifications: How Generic Drug Makers Legally Challenge Patents
Paragraph IV certifications let generic drug makers legally challenge brand-name patents before launch. This Hatch-Waxman Act mechanism saves billions in healthcare costs and drives generic competition in the U.S.
Paragraph IV Certifications: How Generic Drug Makers Legally Challenge Brand Patents
Paragraph IV certifications let generic drug makers legally challenge brand-name patents before market entry. This Hatch-Waxman Act tool drives competition, saves billions, and offers 180-day exclusivity to winners - but only if they navigate complex legal risks.